Inflammation induced by infection or injury induces synthesis of a number of proteins which normally are expressed at a very low level. These proteins are also known as acute-phase proteins. Synthesis of serum amyloid A (SAA) protein, a member of the acute-phase proteins, can increase as much as 1,000-fold in response to inflammatory signals (reviewed in reference 21). Aberrant expression of SAA during chronic inflammatory conditions is linked with many diseases (4) . In amyloidosis, an N-terminal fragment of SAA, termed amyloid A protein, is deposited in the extracellular areas of various organs including kidney, spleen, heart, and liver. Recent studies have suggested that SAA may be involved in the pathogenesis of atherosclerosis by altering cholesterol metabolism (12, 27, 44, 45) . SAA has an ability to associate with high-density lipoprotein (HDL) by displacing apoA1 protein from it. Since apoA1 is the most efficient acceptor of cholesterol and is required as an activator of lecithin-cholesterol acetyltransferase reaction, SAA-rich HDL has a lesser capacity to metabolize cholesterol. Also, SAA-rich HDL particles have a much shorter half-life than HDL particles lacking SAA. Consequently, under chronic inflammatory conditions, persistent high levels of SAA can decrease the clearance rate of cholesterol and increase the risk of cardiovascular disease.
Although SAA biosynthesis primarily occurs in the liver during inflammation, it is also expressed in many other organs including kidney, spleen, and lung cells; adipocytes; vascular cell wall; and monocyte/macrophage cells. Understanding the mechanism of SAA biosynthesis especially in extrahepatic tissues is gaining more attention because many pathological conditions, such as rheumatoid arthritis, amyloidosis, and atherosclerosis, that are linked to abnormal SAA expression are manifested in nonhepatic organs. Increased SAA synthesis during inflammation is attributed primarily to the transcriptional induction of this gene (24) . By transient transfection and mutation analysis, we and others have identified multiple transcriptional regulatory elements in the SAA promoter. These regions include a functional NF-B DNA-binding element (5, 14, 22, 38) , two C/EBP DNA-binding elements (5, 14, 16, 33, 34) , and a promoter element known as SAA-activating sequence (SAS) (36) . C/EBP and NF-B DNA-binding elements are shown to be important for the transcriptional induction of the SAA gene in the liver. During inflammatory episodes when both NF-B and the C/EBP family of proteins are increased and activated, they form a heteromeric complex and synergize each other's function (35) . The heteromeric complex of NF-B and C/EBP can efficiently promote SAA transcription from both NF-B and C/EBP sites.
Transcriptional induction of SAA in nonhepatic cells is believed to be largely regulated by the SAS element, as mutation of this region results in a severe loss of inducibility in several nonliver cells (36) . A protein termed SAS-binding factor (SAF) interacts with the SAS promoter element. To better understand the mechanism by which SAF regulates the expression of the SAA gene, we set out to identify and characterize it. Here we report, on the basis of the ability to interact with the SAS element, identification of several cDNA clones that represent the SAF family of transcription factors. Among the three distinctly different cDNA clones, two isoforms, SAF-5 and SAF-8, are unique and not reported elsewhere. The third cDNA clone, SAF-1, is 85% homologous to MAZ/Pur-1/ZF87 (6, 18, 32) , indicating that SAF-1 is a member of this group of transcription factors. All three SAF isoforms have a similar affinity for the SAS element and are able to promote transcription through the SAS element of the SAA promoter. Furthermore, both DNA-binding activity and transactivation potential of SAF isoforms are regulated by posttranslational modification.
antibody interaction studies, anti-SAF antiserum was added to the reaction mixture during a preincubation period of 30 min on ice.
Northern blot analysis. Multiple tissue Northern blot was purchased from Clontech, and RNA was isolated as described elsewhere (10) . Northern blots were hybridized as indicated with either full-length SAF-1 cDNA, 300-bp SAF-5 unique sequences, or 230-bp SAF-8 unique sequences as the probes. Probe cDNAs were labeled by random priming (42) .
In vivo phosphorylation of SAF-1. Cultured HIG82 cells were transfected with expression plasmid pCMVSAF-1. The cells were metabolically labeled with 32 P i (0.5 mCi/ml) in phosphate-free DMEM for 6 h either in the presence or in the absence of okadaic acid (OA) (100 nM). Prior to the labeling, the transfected cells were grown in DMEM supplemented with 5% fetal calf serum for 24 h. The 32 P-labeled cells were harvested, washed quickly in phosphate-free DMEM, and lysed by adding hot lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% Nonidet P-40, 1% sodium dodecyl sulfate [SDS], 3 mM vanadate, 2.5 mM phenylmethylsulfonyl fluoride). After lysis, the lysates were heated at 95°C for 5 min and the SDS concentration was reduced to 0.05% by adding lysis buffer without SDS. The 32 P-labeled SAF was isolated by immunoprecipitation, fractionated in an SDS-12% polyacrylamide gel, and detected by autoradiography.
Western blot analysis. Nuclear extracts (50 g of protein) and transfected cell extracts (50 g of protein) were fractionated in SDS-11% polyacrylamide gels and electroblotted onto nitrocellulose membranes. The membranes were then blocked in phosphate-buffered saline-0.05% Tween 20 supplemented with 5% (wt/vol) nonfat dry milk at room temperature for 1 h. The primary antibody to SAF-1 was diluted 1:1,000 in phosphate-buffered saline-0.05% Tween 20-1% bovine serum albumin and incubated for 1 h at room temperature. Horseradish peroxidase-conjugated goat anti-mouse antibody was used as the secondary antibody. Bands were detected by using a chemiluminescence detection system (Amersham Life Science Ltd.).
Nucleotide sequence accession numbers. The sequences reported in this paper have been deposited in the GenBank database (accession no. AF076784, AF076785, and AF076786).
RESULTS
Multiple DNA-protein complexes are formed by SAF. We previously reported that the Ϫ280 to Ϫ226 region of the SAA promoter designated as SAS is involved in the extrahepatic expression of SAA in response to an inflammatory signal (36) . The sequence of the SAA promoter in this region, hereafter referred to as SAS, is highly rich in pyrimidine nucleotides on the sense strand. A transcription factor termed SAF interacts with this promoter element (36) . As seen in Fig. 1 , the pattern of DNA-protein complexes was somewhat different when different cellular nuclear extracts were used to interact with the SAS element (Ϫ254/Ϫ226). Several DNA-protein complexes were seen when EMSA was performed with both control and stimulated cell nuclear extracts, indicating induction of multiple SAF-like DNA-binding activities in these cells. In THP-1 monocyte nuclear extracts, we observed three LPS-inducible DNA-protein complexes, designated a, b, and c (lanes 1 and 2). Three major DNA-protein complexes were seen with HepG2 liver cell nuclear extract, two of which, aЈ and bЈ, appeared to be induced by IL-6 (lanes 3 and 4). In rabbit synoviocyte cells, induction of two DNA-protein complexes, aЉ and bЉ, was seen when the cells were treated with LPS (lanes 5 and 6). A nonspecific complex, NS, was detected in all three cell types. This complex was not inhibited by a competitor oligonucleotide, and anti-SAF antibody did not ablate and/or supershift this complex (data not shown).
Cloning of cDNA encoding SAF. To isolate a cDNA coding for SAF, we screened a rabbit gt11 cDNA expression library with a concatenated probe containing multiple SASs, nucleotides Ϫ254 to Ϫ226 in the SAA promoter. This search resulted in the identification of eight positive clones that interacted specifically with the SAS promoter. GenBank and EMBL database searches revealed several homologous sequences. The most closely related, MAZ/ZF87/Pur-1, is 85% identical to SAF-1 at the DNA sequence level ( Fig. 2A) . This result indicated that SAF-1 may be a rabbit homolog of MAZ/ZF87/ Pur-1. The rabbit SAF-1 cDNA is about 200 bp longer at the 3Ј end than the human MAZ sequence reported previously (6) , and it encodes a protein with an estimated molecular mass of 52.5 kDa, which is very close to the size of 55 kDa estimated earlier from a UV cross-linking assay (36) . There were no other proteins that showed a strong homology to SAF, except in the zinc finger region. SAF-1 has six zinc finger domains of the Cys 2 -His 2 type, five of which are located at the carboxylterminal half of the molecule. It also contains a proline-rich region at the amino-terminal end and three polyalanine tracts. Two other SAF family members, SAF-5 and SAF-8, were also characterized by DNA sequence analysis. The SAF-5 cDNA sequence is highly homologous with SAF-1 at the carboxylterminal end, and it contains five of six zinc fingers that are present in SAF-1. The N-terminal end of SAF-5 is different from that of SAF-1 and is rich in serine, arginine, glycine, and proline residues. An in-frame ATG codon was found 39 bp downstream of the 5Ј end. Two independent clones of SAF-5 had the same 5Ј ends, suggesting that they contain the complete 5Ј-end sequence. Primer extension analysis (data not shown) also confirmed this possibility. Another clone, SAF-8, contains an insertion of a 230-bp sequence that codes for two additional zinc fingers at the C-terminal end. However, due to this insertion, an apparent frameshift may have created an in-frame TGA codon that precludes downstream common nucleotide sequences coding for a common carboxyl-terminal amino acid in SAF-8. This event resulted in the loss of one polyalanine tract in SAF-8 cDNA, although nucleotide sequences in this region are highly conserved between SAF-1 and SAF-8. Deduced amino acid sequence comparison of the three SAF family members, described for Fig. 2B , shows that homology among all SAF isoforms in the five zinc finger domains is almost 100%, except that SAF-8 has two additional zinc finger sequences (Fig. 2B) . The SAF-8 cDNA clone is believed to be partial and lacks a portion of the upstream coding sequences.
Zinc fingers present at the 3Ј end of all SAF isoforms presumably act as the DNA-binding domains. The proline-rich region in SAF-1 and a serine-arginine-proline-glycine-rich region in SAF-5 may function as transcriptional activation domains. The activation domain of several other members of the Cys 2 -His 2 class of zinc finger proteins has been found to contain similar amino acid residues (29) . The three polyalanine tracts in SAF-1 and one polyalanine tract in SAF-5 may be involved in the formation of ␣-helical structure, as they have been found in the Drosophila runt (17) , engrailed (31) , and evenskipped (26) genes. One notable feature in the amino-terminal region of SAF-5 ( Fig. 2B , amino acids 77 to 84) is the potential peptide sequence that resembles SH3 ligand. Proteins carrying the SH3 domain are known to recognize a similar peptide element (1). SAF-5 may, therefore, as an SH3 ligand, be involved in protein-protein interaction with SH3-containing proteins. The amino acid sequence of the three SAF clones revealed several possible sites of phosphorylation. In SAF-1 and SAF-5, a PXTP sequence identified as the consensus phosphorylation site for mitogen-activated protein (MAP) kinases is present (2). MAP kinases (11, 41, 46) are known to be activated in response to a variety of inflammatory signals in various tissues, a condition in which the SAA gene is also induced. Also, possible phosphorylation sites for protein kinase C are identified in SAF isoforms.
Bacterially expressed SAF proteins can interact with the SAS element. The identity of cloned SAF-1 cDNA as one coding for an SAF protein was first verified by the DNAbinding ability of the expressed protein. Bacterially expressed SAF-1 protein efficiently interacted with the SAS probe (Fig.  3A) . The DNA-protein complex was eliminated by the homologous competitor but not by an unrelated oligonucleotide (lanes 2 and 3). For further characterization of the cloned gene, we used antibody raised against the cloned recombinant SAF-1 in the DNA-binding assay of nuclear proteins (Fig. 3B ). All specific complexes were neutralized by the anti-SAF-1 antibody. Only one complex which was previously characterized as a nonspecific (NS) complex (Fig. 1) was unaffected by the antibody. Preabsorbed anti-SAF-1 antibody had no inhibitory effect on the DNA-protein complex formation (data not shown). This indicated that the cloned SAF-1 cDNA expresses SAF protein. Bacterially expressed SAF-5 and SAF-8 proteins can efficiently interact with the SAA promoter (Fig. 3C , lanes 1 to 6). Formation of these complexes is inhibited by anti-SAF-1 antibody and not by preabsorbed antibody (data not shown).
Relative affinities of the three SAF isoforms for the SAS element. We were interested to know whether the three SAF isoforms differed in terms of their binding affinities for the SAS element. To test this possibility, we constructed a series of oligonucleotides containing slightly altered SAF-binding elements. These altered oligonucleotides were analyzed for their ability to compete with the wt probe for binding to three different bacterially expressed SAF proteins in the DNA-binding assay. As shown in Fig. 3D , introduction of mutant bases allowed these oligonucleotides to compete variably, among which mt5 SAS oligonucleotide did not compete at all. With these different oligonucleotides, however, no significant difference in the recognition pattern among the three SAF isoforms was noticed, which led us to conclude that bacterially expressed SAF-1, SAF-5, and SAF-8 bind indistinguishably to the SAS element of the SAA promoter.
SAF can transactivate an SAA promoter. To assess the functional activity of SAF-1 in vivo, we cotransfected a reporter gene containing one copy of SAA promoter element (Ϫ280/ Ϫ226) with increasing concentrations of an expression plasmid FIG. 1. Band shift of the rabbit SAS element with the nuclear extracts of control and stimulated cells. A radiolabeled SAS element, the sequence from Ϫ254 to Ϫ226, was incubated with 10 g of unstimulated (lanes 1, 3, and 5) and stimulated (lanes 2, 4, and 6) cell nuclear extracts. The resulting complexes were resolved in a 6% nondenaturing polyacrylamide gel. Lanes 1 and 2, THP-1 monocyte/macrophage cell nuclear extract; lanes 3 and 4, HepG2 liver cell nuclear extract; lanes 5 and 6, HIG82 synoviocyte cell nuclear extract. THP-1 and HIG82 cells were stimulated with LPS (10 g/ml) for 24 h, and HepG2 cells were stimulated with 500 U of IL-6 per ml for 24 h. NS, nonspecific.
DNA encoding SAF-1 cDNA. Overexpression of SAF-1 induced the reporter gene activity in a dose-dependent manner (Fig. 4A) . The rate of transactivation was much higher when the reporter gene contained three tandem copies of the SAS element (data not shown). Similar results were also obtained when we cotransfected cells with expression plasmids encoding SAF-5 and SAF-8 cDNAs (data not shown). It should be noted that overexpression of SAF was sufficient for transactivation of the reporter gene, and it did not require any further stimulation by LPS or cytokines. Interestingly, SAF-1 transactivated the reporter CAT gene at a much lower level in the HepG2 liver cells than in three other cell types. To determine if such a low rate of transactivation in HepG2 cells was due to any defect in the expression of the transfected SAF-1 plasmid DNA, we performed a Western blot analysis. The same four cell types were transiently transfected with equal amounts of pCMVSAF-1 DNA, and protein extracts prepared from these cells were fractionated in a polyacrylamide gel, transferred onto nitrocellulose membrane, and probed with anti-SAF-1 antibody. As seen in Fig. 4B , transfected SAF-1 was expressed at similar levels in HepG2 and three nonhepatic cell types. Since the protein level of transfected SAF-1 was the same, it can be argued that differential transactivation is not caused by different interactions of SAF-1 with the SAA promoter. Rather, the difference probably results from a function that acts more directly to modify or augment the DNA-binding property or transactivation property of SAF-1. 1 and 2) or LPS-treated rabbit synoviocyte cell nuclear extract (lanes 3 and 4). In lanes 2 and 4, antibodies prepared against bacterially expressed SAF protein were added. (C) A partially purified preparation of bacterially expressed SAF-5 (lanes 1 to 3) or SAF-8 (lanes 4 to 6) protein (1 g) was incubated with radiolabeled SAS oligonucleotide. In addition, a 100-fold molar excess (30 ng) of wt SAS oligonucleotide (lanes 2 and 5) or a nonspecific oligonucleotide (lanes 3 and 6) was added as a competitor. (D) Relative affinities of SAF-1 (solid line), SAF-5 (dotted line), and SAF-8 (dashed line) proteins for various SAS oligonucleotides (sequences are described in Materials and Methods). Binding reactions were performed with 1 g of bacterially expressed purified SAF proteins, 32 P-labeled SAA (Ϫ254/Ϫ226) probe, and the indicated amounts of unlabeled double-stranded oligonucleotides. The concentration of the unlabeled oligonucleotides is indicated on the abscissa; the amount of the residual complex, expressed as a percentage of that found in the absence of competitor (100%), is indicated on the ordinate. Binding activity was quantitated by densitometry of the DNA-protein complex formed by the interaction of each SAF isoform and SAS probe. VOL. 18, 1998 SAFs, A FAMILY OF Cys 2 -His 2 ZINC FINGER PROTEINShybridization probe. As shown in Fig. 5A , SAF transcripts are expressed widely in the adult tissues but at varying level. Two mRNAs of 2.7 and 4.5 kb in size were detected, of which the 2.7-kb band was more prominent. The hierarchy of SAF mRNA concentrations is brain Ͼ testis Ͼ liver Ͼ lung Ͼ heart Ͼ skeletal muscle Ͼ kidney Ͼ spleen. Upon longer exposure, a 5.0-kb mRNA in brain tissue, a 2.0-kb mRNA in lung tissue, and a 1.4-kb mRNA in liver and kidney cells were detected. Detection of multiple transcripts indicated that SAF belongs to a family of proteins that are of variable size, and their expression level is not similar in all tissues. To determine the expression pattern of SAF-5 that has a different aminoterminal end, we used a 300-bp unique sequence as a hybridization probe. We detected a 1.4-kb mRNA predominantly expressed in skeletal muscle tissue (Fig. 5B) . Because the SAF-5 clone was isolated from a brain cDNA library, it is anticipated that SAF-5 is also expressed in brain tissue, albeit at a much lower level. SAF-8 mRNA expression was analyzed by using a 230-bp sequence containing two unique zinc finger domains as a probe. The SAF-8 probe detected a 2.7-kb mRNA that is present at almost equal levels in all tissues (Fig.  5C ). DNA-binding activity and transactivating ability of SAF are regulated by a phosphorylation event. We next determined whether the increased DNA-binding activity of SAF in THP-1 monocyte and HIG82 synoviocyte cells induced by LPS (Fig. 1) is due to increased gene transcription and/or posttranslational modification. In a Northern blot analysis, total RNA isolated from untreated and 24-h LPS-treated THP-1 monocyte/macrophage and HIG82 synoviocyte cells was fractionated and probed with SAF-1 coding sequence. The relative amount of SAF-1 mRNA remained virtually unchanged upon LPS treatment of the cells, indicating that LPS-mediated increased DNA-binding activity of SAF may be due to some posttranslational modification of this protein (data not shown). A previous study (36) indicated that DNA-binding activity of SAF is reduced upon dephosphorylation of the nuclear extracts in vitro by alkaline phosphatase. Consequently, we first examined whether in vivo inhibition of endogenous phosphatase activity leads to any changes in the DNA-binding activity of SAF. THP-1 cells were treated with OA, a serine/threonine phosphatase inhibitor, for different lengths of time, up to 24 h. DNA-binding assays with the SAA probe, using untreated and various OA-treated nuclear extracts, indicated that SAF DNAbinding activity was gradually increased by OA treatment (Fig.  6A, lanes 1 to 5) . When the cells were treated with H7, which inhibits endogenous protein kinases, DNA-binding activity of SAF was severely reduced (Fig. 6B, lane 3) . To determine if such treatment resulted in a change of SAF protein level, we performed a Western blot analysis (Fig. 6C) , by using nuclear extracts prepared from untreated, OA-treated, and H7-treated THP-1 cells. The anti-SAF antibody detected no change in the level of SAF protein. This result indicated that the change in the DNA-binding activity of SAF during treatments with OA and H7 (Fig. 6B) is mainly due to a posttranslational modification.
To further verify that the activity of SAF is modified by a phosphorylation event, we cotransfected pSAS-CAT2 and pmtSAS-CAT2 reporter genes with and without pCMVSAF-1 DNA and incubated the transfected cells in the presence or absence of OA. Inhibition of some endogenous serine/threonine phosphatases stimulated in vivo transactivating ability of SAF by severalfold (Fig. 7A) . Sodium orthovanadate, which inhibits tyrosine phosphatase activity, had some stimulatory effect on reporter gene and SAF transactivation potential. Reciprocally, incubation of transfected cells with H7, a serine/ threonine protein kinase inhibitor, severely reduced the transactivating ability of SAF. Since expression of the pmtSAA-CAT reporter gene was not affected under these conditions, we conclude that DNA-binding ability as well as transactivating ability of SAF may be regulated by a phosphorylation event.
For further examination, we transfected HIG82 cells with cloned pCMVSAF-1 DNA and incubated the cells in the presence or absence of OA. As seen in Fig. 7B , OA considerably stimulated the DNA-binding activity of transfected SAF-1 cDNA. Western blot analysis of the transfected cellular proteins indicated that this increase was not due to any increase of transfected SAF-1 protein content (Fig. 7C) during OA treatment. Taken together, these results suggested that phosphorylation may play a key role in the activation of the SAF-1 gene.
To determine if indeed SAF-1 is hyperphosphorylated in the presence of OA, we labeled pCMVSAF1-transfected HIG82 cells with 32 P i and immunoprecipitated the 32 P-labeled cellular proteins with anti-SAF-1 antibody. As seen in Fig. 7D , cells transfected with SAF-1 expression plasmid revealed a phosphorylated protein band (lanes 1 and 2) , the intensity of which increased when the cells were labeled in the presence of a protein phosphatase inhibitor, OA (lane 2). This increase of phosphorylation was not due to any increase in the expression of the transfected SAF-1 gene, because the level of SAF-1 protein was the same during OA treatment (Fig. 7C) .
DISCUSSION
Higher-level expression of SAA in response to chronic inflammatory conditions is linked to a number of pathophysiological conditions, including amyloidosis, arthritis, and atherosclerosis. Previous studies showed that the SAS promoter element of the SAA gene controls its expression and that a novel transcription factor, designated SAF, interacts with this element (36) . In this report, we describe the cloning of the cDNA of SAF. The novel findings and conclusions drawn from this study are as follows: (i) SAF belongs to a family of related proteins that have common zinc finger domains at their car- boxyl end, (ii) expression of an SAF isoform is tissue specific, (iii) the DNA-binding activity of SAF is increased in response to cytokine or LPS treatment of the cells, and (iv) posttranslational modifications increase DNA-binding and transactivating abilities of SAF.
Among three distinct SAF isoforms, SAF-1 appears to be a rabbit homolog of human MAZ/ZF87 (6, 32) and mouse Pur-1 (18) . MAZ/ZF87 was shown to regulate expression of c-myc (6, 32) and serotonin 1A receptor (30) genes, while Pur-1 was identified as a regulator of insulin (18) gene expression. These previous studies (6, 18, 30, 32) suggested that MAZ/ZF87/ Pur-1 is a constitutive widely expressed transcription factor that is present in most, if not all, tissues. However, expression of the serotonin 1A receptor gene is highly tissue specific, developmentally regulated, and controlled by hormones. Similarly, the insulin gene is subject to strict transcriptional controls, both at the level of tissue specificity and in its metabolic regulation. Consequently, how constitutively expressed MAZ/ ZF87/Pur-1 can regulate expression of these genes was not fully explained. Our study, which identifies tissue-specific, inflammation-responsive, and posttranslationally modified activation of SAF, will be useful in explaining regulated expression of serotonin 1A receptor and insulin genes. Interestingly, the putative SAF-binding element is present in the promoter region of several other inflammation-or acute-phase-responsive genes (Fig. 8) . In the human C-reactive protein gene, the potential SAF binding element partially overlaps the STAT3 binding element (51) . A previous report (20) identified IL-6-responsive regulatory elements between Ϫ852 and Ϫ777 bp of the rat ␣2M gene promoter. This region contains a putative SAF-binding element. The functional importance of these potential SAF-binding elements remains to be experimentally determined.
The expression pattern of SAF family members is quite complex. Although transcripts of SAF-1 were identified in most tissues, we believe this ubiquitous expression pattern (Fig. 5A) arises due to the cross-hybridization of probe with different family members. By using unique sequences of SAF-5, we showed that this isoform is predominantly expressed in skeletal muscle tissue (Fig. 5B) .
SAF is a strong transcriptional activator in different cell types when tested on the SAA promoter with one copy, as well as multimerized units of SAF-binding elements. SAF-1 contains clusters of proline residues like those present in WT-1 (8) and CTF (28) transcription factors. It has been proposed that clusters of proline amino acids can adopt a structure known as the polyproline II helix (49) . RNA polymerase II has such a domain, which is suggested to be involved in interacting with the TFIID transcription initiation complex (19) . Multiple proteins may interact via these proline-rich regions to form an optimum preinitiation complex for transcription. We recently reported that SAF can interact with Sp1 to form an SAF-Sp1 heteromeric complex which has a higher level of transactivation potential than SAF or Sp1 alone (39, 40) . It will be interesting to know whether the proline-rich domain of SAF is involved in such an interaction.
One other important finding of this study is the phosphorylation-mediated activation of SAF-1 DNA-binding activity. We have shown that OA, a serine/threonine protein phosphatase inhibitor, can increase the DNA-binding ability of SAF as well as its transactivation potential, while the protein kinase inhibitor H7 acts reciprocally ( Fig. 6 and 7) . Consistent with these results, in SAF sequences, several potential sites for phosphorylation, including those of protein kinase C and MAP kinases, have been located (Fig. 2) . It is intriguing that simple inhibition of the endogenous phosphatases can increase the DNA-binding as well as the transactivating ability of SAF. The induction of SAF activity by OA appears to be slow and is detected at 4 h after the addition of OA. This result is unlike those with some other transcription factors, such as STAT3 (48) or NF-B (3), that are quickly activated, usually within minutes, by posttranslational modification. The slow kinetics of SAF induction in the presence of OA may be explained by assuming the presence of a constitutive but low level of endogenous protein kinase activity that can phosphorylate and increase the DNAbinding activity of SAF. OA, by inhibiting some endogenous protein phosphatase, may allow a gradual increase of the phosphorylated form of SAF. Since the phosphorylated form of SAF can be increased by OA (Fig. 7D) , it suggests that protein phosphatases are also involved in the regulation of SAF phosphorylation. Indeed, a similar phenomenon has been observed in the case of cyclic AMP-regulated binding protein (CREB), which is stimulated by cyclic AMP-dependent protein kinase A-mediated phosphorylation. Nuclear protein phosphatase 2A specifically dephosphorylates protein kinase A-phosphorylated CREB (47) and attenuates CREB-mediated transcriptional activation of many eucaryotic genes. Whatever the mechanism, the results presented here suggest that SAF activation by a phosphorylation event may be a dynamic process involving an intricate balance between active phosphorylation and dephosphorylation events in order to establish a steady-state level. 
